PERK — Perk Labs Income Statement
0.000.00%
Last trade - 00:00TechnologyHighly SpeculativeMicro Cap
Annual income statement for Perk Labs, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
R2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.04 | 0.032 | 0.064 | 0.029 | 0.032 |
| Cost of Revenue | |||||
| Gross Profit | — | — | -0.004 | 0.002 | 0.009 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 16 | 8 | 2.95 | 2.91 | 2.57 |
| Operating Profit | -13.9 | -7.96 | -2.89 | -2.88 | -2.54 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13 | -8.08 | -4.49 | -1.49 | -3.38 |
| Net Income After Taxes | -13 | -8.08 | -4.49 | -1.49 | -3.38 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -13 | -8.08 | -4.49 | -1.49 | -3.38 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13 | -8.08 | -4.49 | -1.49 | -3.38 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.086 | -0.055 | -0.034 | -0.01 | -0.018 |